Skip to main content
Faes Farma S.A. logo

Faes Farma S.A. — Investor Relations & Filings

Ticker · FAE ISIN · ES0134950F36 LEI · 959800FXZQY7U3P1G969 MC Manufacturing
Open in API
Filings indexed 193 across all filing types
Latest filing 2026-02-26 Annual Report
Country ES Spain
Listing MC FAE

About Faes Farma S.A.

https://faesfarma.com/en/

Faes Farma S.A. is a pharmaceutical company engaged in the research, development, manufacturing, and marketing of pharmaceutical products, healthcare solutions, and animal nutrition products. The company's pharmaceutical division develops treatments for conditions in therapeutic areas including allergy, gastroenterology, and immunology, with key proprietary molecules such as Bilastine, a leading antihistamine, and Calcifediol for Vitamin D deficiency. The animal nutrition business provides nutritional solutions and supplements for sustainable animal production. A core focus of the company is its investment in R&D to develop novel molecules and health solutions for its global markets.

Recent filings

Filing Released Lang Actions
Annual Report for Faes Farma S.A. (2026)
Annual Report Classification · 100% confidence The document contains comprehensive consolidated financial statements, including the balance sheet, income statement, statement of comprehensive income, statement of changes in equity, cash flow statement, and detailed notes (Memoria). The presence of full financial data for the fiscal year ending December 31, 2025, and the explicit mention of 'cuentas anuales consolidadas' (consolidated annual accounts) confirms this is an Annual Report. It is not an announcement (RPA) as it contains the full financial data and notes. FY 2025
2026-02-26 English
Annual Report (ESEF) for Faes Farma S.A. (2026)
Annual Report Classification · 100% confidence The document contains comprehensive consolidated financial statements (Balance Sheet, Income Statement, Statement of Comprehensive Income, Statement of Changes in Equity, and Cash Flow Statement) for Faes Farma, S.A. for the fiscal year ending December 31, 2025. It includes detailed notes to the financial statements and follows the IFRS reporting standards. As it provides full financial performance and activity for the year, it is classified as an Annual Report (10-K). FY 2025
2026-02-26 Spanish
Annual / Quarterly Financial Statement for Faes Farma S.A. (2026)
Annual Report Classification · 100% confidence The document contains the full financial statements (Balance Sheet, Profit and Loss, Statement of Changes in Equity, Cash Flow Statement, and Notes to the Accounts) for Faes Farma, S.A. for the fiscal year ending December 31, 2025. It is a comprehensive annual financial report, not an announcement or a summary. Therefore, it is classified as an Annual Report (10-K). Q1 2024
2026-02-26 English
Annual Report for Faes Farma S.A. (2026)
Annual Report Classification · 100% confidence The document contains comprehensive consolidated financial statements, including the balance sheet, income statement, statement of comprehensive income, statement of changes in equity, cash flow statement, and detailed notes (Memoria). The presence of full financial data for the fiscal year ending December 31, 2025, and the explicit mention of 'cuentas anuales consolidadas' (consolidated annual accounts) confirms this is an Annual Report. It is not an announcement (RPA) as it contains the full financial data and notes. FY 2025
2026-02-26 English
Annual Report (ESEF) for Faes Farma S.A. (2026)
Annual Report Classification · 100% confidence The document contains comprehensive consolidated financial statements (Balance Sheet, Income Statement, Statement of Comprehensive Income, Statement of Changes in Equity, and Cash Flow Statement) for Faes Farma, S.A. for the fiscal year ending December 31, 2025. It includes detailed notes to the financial statements and follows the IFRS reporting standards. As it provides full financial performance and activity for the year, it is classified as an Annual Report (10-K). FY 2025
2026-02-26 Spanish
Faes Farma anuncia la celebración de un webcast para presentar los resultados del 2025
Report Publication Announcement Classification · 95% confidence The document is a short announcement (under 5,000 characters) addressed to the CNMV (Spanish regulator) regarding an upcoming webcast for the presentation of 2025 financial results. It does not contain the actual financial report or the transcript of the call, but rather serves as a notification of the event and how to access it. According to the 'Menu vs Meal' rule, this is a regulatory announcement regarding the scheduling of an event/report, fitting the criteria for a Regulatory Filing (RNS).
2026-02-24 Spanish

Browse filings by year

32 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.